Shilpa Medicare Ltd (SHILPAMED) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 780523, "name": "Shilpa Medicare", "stock_name": "Shilpa Medicare", "full_name": "Shilpa Medicare Ltd", "name_url": "stocks-analysis/shilpa-medicare", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "409.80", "chg": -5.7, "chgp": "-1.37%", "dir": -1, "prev_price": "415.50", "mcapval": "8,014.94 Cr", "mcap": "Small Cap", "scripcode": 530549, "symbol": "SHILPAMED", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE790G01031", "curr_date": "Apr 28", "curr_time": "", "bse_nse_vol": "2.35 lacs", "exc_status": "Active", "traded_date": "Apr 28, 2026", "traded_date_str": "2026 04 28", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shilpa-medicare-780523-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Shilpa Medicare Downgraded to Sell Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3965884", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShilpaMedicareL_mojoScore_3965884.png", "date": "2026-04-28 08:31:57", "description": "Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 27 Apr 2026. This revision reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments that collectively signal caution for investors despite recent positive quarterly results." }, { "title": "Shilpa Medicare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3965618", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShilpaMedicareL_technicaldot_3965618.png", "date": "2026-04-28 08:04:13", "description": "Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a modest day gain of 0.41%, the company’s technical indicators present a complex picture, with bullish signals on some fronts and bearish or neutral cues on others, prompting a downgrade in its Mojo Grade from Hold to Sell as of 27 Apr 2026." }, { "title": "Shilpa Medicare Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-is-rated-hold-by-marketsmojo-3962265", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShilpaMedicareL_mojoScore_3962265.png", "date": "2026-04-25 10:10:03", "description": "Shilpa Medicare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 2 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "Shilpa Medicare Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-is-rated-hold-3945725", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShilpaMedicareL_mojoScore_3945725.png", "date": "2026-04-14 10:10:02", "description": "Shilpa Medicare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 April 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Shilpa Medicare Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-3933753", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShilpaMedicareL_technicaldot_3933753.png", "date": "2026-04-06 08:01:51", "description": "Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for investors as the stock price advances to ₹388.00, up 3.69% on 6 Apr 2026." }, { "title": "Shilpa Medicare Gains 11.09%: 3 Key Factors Driving the Week’s Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-gains-1109-3-key-factors-driving-the-weeks-rally-3932092", "imagepath": "", "date": "2026-04-04 16:00:03", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>30 Mar:</strong> Stock opens week at Rs.348.65 amid broad market weakness</p>\n <p><strong>1 Apr:</strong> Intraday high of Rs.376.20 with a 7.84% surge and strong gap up</p>\n <p><strong>2 Apr:</strong> Continued gains to Rs.388.75 supported by technical upgrades</p>\n <p><strong>3 Apr:</strong> MarketsMOJO upgrades rating to Hold reflecting improved fundamentals</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.348.65</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week ..." }, { "title": "Shilpa Medicare Ltd Upgraded to Hold: A Detailed Analysis of Quality, Valuation, Financial Trend and Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-upgraded-to-hold-a-detailed-analysis-of-quality-valuation-financial-trend-and-technicals-3931268", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShilpaMedicareL_mojoScore_3931268.png", "date": "2026-04-03 08:10:16", "description": "Shilpa Medicare Ltd has seen its investment rating upgraded from Sell to Hold as of 2 April 2026, reflecting notable improvements across technical indicators, valuation metrics, and financial performance. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that have driven this change, providing investors with a detailed understanding of the company’s current standing within the Pharmaceuticals & Biotechnology sector." }, { "title": "Shilpa Medicare Ltd Surges 7.84% to Day's High of Rs 376.2 — Outperforms Sector by 5.77 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-hits-intraday-high-with-784-surge-on-1-april-2026-3928765", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShilpaMedicareL_priceRelatedfactors_3928765.png", "date": "2026-04-01 10:22:29", "description": "The Sensex advanced 2.49% on 1 Apr 2026, yet Shilpa Medicare Ltd outpaced the broader market with a 7.84% gain, reaching an intraday high of Rs 376.2. This 5.77-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector’s 2.07% rise signals a distinctly stock-specific surge rather than a mere market tailwind." }, { "title": "Shilpa Medicare Ltd Opens 5.06% Higher Amid Mixed Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-opens-strong-with-significant-gap-up-amid-positive-market-sentiment-3927924", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShilpaMedicareL_gapup_3927924.png", "date": "2026-04-01 09:33:59", "description": "" } ], "total": 389, "sid": "780523", "stock_news_url": "https://www.marketsmojo.com/news/shilpa-medicare-780523" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Change in Management", "datetime": "23-Apr-2026", "details": "Appointment of Dr. Vellaian Karuppiah as Chief Operating Officer (COO)- Formulations - Senior Managerial Personnel.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Change in Management", "datetime": "22-Apr-2026", "details": "Retirement of Senior Managerial Personnel (SMP)", "source": "BSE" }, { "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A", "datetime": "09-Apr-2026", "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Shilpa Medicare Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85110KA1987PLC008739</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>A+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>INDIA RATINGS AND RESEARCH PVT. LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: MS RITU TIWARY <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: CS@VBSHILPA.COM</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: MR ALPESH DALAL <br/> Designation: CFO <br/> EmailId: apleshdalal@vbshilpa.com</div> </div> <div> <br/> Date: 09/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Shilpa Medicare Ltd has declared <strong>100%</strong> dividend, ex-date: 17 Sep 25", "dt": "2025-09-17", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Shilpa Medicare Ltd has announced <strong>1:2</strong> stock split, ex-date: 06 Nov 15", "dt": "2015-11-06", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Shilpa Medicare Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 03 Oct 25", "dt": "2025-10-03", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

30 Mar: Stock opens week at Rs.348.65 amid broad market weakness

1 Apr: Intraday high of Rs.376.20 with a 7.84% surge and strong gap up

2 Apr: Continued gains to Rs.388.75 supported by technical upgrades

3 Apr: MarketsMOJO upgrades rating to Hold reflecting improved fundamentals

Week Open

Rs.348.65

Week ...

Read full news article

Shilpa Medicare Ltd Upgraded to Hold: A Detailed Analysis of Quality, Valuation, Financial Trend and Technicals

2026-04-03 08:10:16

Shilpa Medicare Ltd has seen its investment rating upgraded from Sell to Hold as of 2 April 2026, reflecting notable improvements across technical indicators, valuation metrics, and financial performance. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that have driven this change, providing investors with a detailed understanding of the company’s current standing within the Pharmaceuticals & Biotechnology sector.

Read full news article

Shilpa Medicare Ltd Surges 7.84% to Day's High of Rs 376.2 — Outperforms Sector by 5.77 Percentage Points

2026-04-01 10:22:29

The Sensex advanced 2.49% on 1 Apr 2026, yet Shilpa Medicare Ltd outpaced the broader market with a 7.84% gain, reaching an intraday high of Rs 376.2. This 5.77-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector’s 2.07% rise signals a distinctly stock-specific surge rather than a mere market tailwind.

Read full news article

Shilpa Medicare Ltd Opens 5.06% Higher Amid Mixed Technical Signals

2026-04-01 09:33:59

Read full news article

Sr. No.	Particulars	Details
1	Name of Company	Shilpa Medicare Ltd
2	CIN NO.	L85110KA1987PLC008739
3	Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)	0.00
4	Highest Credit Rating during the previous FY	A+
4a	Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)	INDIA RATINGS AND RESEARCH PVT. LTD.
5	Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework	BSE